|Articles|January 18, 2002
CDER News 1/3/2002
Author(s)BioPharm International Editors
Drug approvals
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
3
Containment to Protection: Packaging Trends Impacting Biopharma
4
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
5